Oscar Health IPO: Pricing, Valuation & Stock Details

Oscar Health IPO Pricing and Initial Performance

Oscar Health, a medical insurance provider leveraging technology, finalized its initial public offering (IPO) late last night, setting the price at $39 per share.

This final price represents a $1 increase compared to the previously adjusted IPO guidance.

Originally, Oscar Health had projected a per-share IPO price within the range of $32 to $34.

Share Sales and Demand

A total of 37,041,026 shares were sold at the $39 price point.

Of these, 36,391,946 shares were directly offered by the company itself.

Excluding shares allocated to underwriters, Oscar Health generated demand exceeding $1.44 billion for its equity at $39 per share.

Over 98% of the proceeds from the overall share sale were deposited into the company’s accounts.

Financial Gains for Backers

The IPO represents a significant financial success for early investors including Thrive Capital, Founders Fund, Formation 8, CapitalG, Fidelity, Alphabet, Coatue, and Tiger Global.

Company Valuation

Determining the company’s worth at $39 per share requires careful calculation, particularly given the number of shares sold during the IPO.

The company’s basic IPO valuation is approximately $7.92 billion.

Renaissance Capital estimates the fully diluted valuation, which includes unexercised options, to be around $9.5 billion.

Successes and Market Implications

Oscar Health’s IPO has proven successful on multiple fronts.

The company secured more funding than initially anticipated, exceeding its original price range.

The current valuation is a substantial increase compared to its last private valuation of $3.2 billion, established during its 2018 Series G funding round.

While additional private capital was raised after that round, specific valuation details remain unavailable.

Looking Ahead

Trading will commence this morning, serving as a key test for the insurtech sector, and specifically, the medical insurtech sub-segment.

The public market has now established a new valuation for Oscar Health.

The company’s performance following its public debut will be closely monitored.

Early Stage Event Announcement

Early Stage is a leading event designed to provide practical guidance for startup entrepreneurs and investors.

Attendees will gain insights directly from successful founders and venture capitalists regarding business development, fundraising, and portfolio management.